vs
Dime Community Bancshares, Inc.（DCOM）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是Dime Community Bancshares, Inc.的1.0倍（$127.1M vs $123.8M），Dime Community Bancshares, Inc.同比增速更快（3040.1% vs 17.1%），过去两年Dime Community Bancshares, Inc.的营收复合增速更高（22.9% vs 20.8%）
戴姆社区银行前身是威廉斯堡戴姆储蓄银行，是受FDIC保险的本土银行，1864年创立，最初扎根于纽约布鲁克林威廉斯堡社区，至今在该区域仍保有强劲的市场影响力，目前总部设于纽约州霍波格，2021年已完成与布里奇 Bancorp 的合并。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
DCOM vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.0倍
$123.8M
营收增速更快
DCOM
高出3023.0%
17.1%
两年增速更快
DCOM
近两年复合增速
20.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $127.1M |
| 净利润 | — | — |
| 毛利率 | — | 51.0% |
| 营业利润率 | 38.6% | -54.6% |
| 净利率 | — | — |
| 营收同比 | 3040.1% | 17.1% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.68 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCOMZLAB
| Q4 25 | $123.8M | $127.1M | ||
| Q3 25 | $115.6M | $115.4M | ||
| Q2 25 | $109.7M | $109.1M | ||
| Q1 25 | $103.8M | $105.7M | ||
| Q4 24 | $3.9M | $108.5M | ||
| Q3 24 | $87.6M | $101.8M | ||
| Q2 24 | $87.3M | $100.1M | ||
| Q1 24 | $82.0M | $87.1M |
净利润DCOMZLAB
| Q4 25 | — | — | ||
| Q3 25 | $27.7M | $-36.0M | ||
| Q2 25 | $29.7M | $-40.7M | ||
| Q1 25 | $21.5M | $-48.4M | ||
| Q4 24 | — | — | ||
| Q3 24 | $13.3M | $-41.7M | ||
| Q2 24 | $18.5M | $-80.3M | ||
| Q1 24 | $17.7M | $-53.5M |
毛利率DCOMZLAB
| Q4 25 | — | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | — | 60.6% | ||
| Q1 25 | — | 63.6% | ||
| Q4 24 | — | 61.5% | ||
| Q3 24 | — | 64.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 61.4% |
营业利润率DCOMZLAB
| Q4 25 | 38.6% | -54.6% | ||
| Q3 25 | 34.7% | -42.3% | ||
| Q2 25 | 36.6% | -50.3% | ||
| Q1 25 | 27.6% | -53.3% | ||
| Q4 24 | -433.6% | -62.6% | ||
| Q3 24 | 20.8% | -66.6% | ||
| Q2 24 | 29.8% | -76.0% | ||
| Q1 24 | 29.6% | -80.7% |
净利率DCOMZLAB
| Q4 25 | — | — | ||
| Q3 25 | 23.9% | -31.2% | ||
| Q2 25 | 27.1% | -37.3% | ||
| Q1 25 | 20.7% | -45.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 15.2% | -40.9% | ||
| Q2 24 | 21.2% | -80.2% | ||
| Q1 24 | 21.6% | -61.4% |
每股收益（稀释后）DCOMZLAB
| Q4 25 | $0.68 | $-0.05 | ||
| Q3 25 | $0.59 | $-0.03 | ||
| Q2 25 | $0.64 | $-0.04 | ||
| Q1 25 | $0.45 | $-0.04 | ||
| Q4 24 | $-0.58 | $-0.09 | ||
| Q3 24 | $0.29 | $-0.04 | ||
| Q2 24 | $0.43 | $-0.08 | ||
| Q1 24 | $0.41 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $715.5M |
| 总资产 | $15.3B | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DCOMZLAB
| Q4 25 | — | $689.6M | ||
| Q3 25 | — | $717.2M | ||
| Q2 25 | — | $732.2M | ||
| Q1 25 | — | $757.3M | ||
| Q4 24 | — | $779.7M | ||
| Q3 24 | — | $616.1M | ||
| Q2 24 | — | $630.0M | ||
| Q1 24 | — | $650.8M |
股东权益DCOMZLAB
| Q4 25 | $1.5B | $715.5M | ||
| Q3 25 | $1.5B | $759.9M | ||
| Q2 25 | $1.4B | $791.7M | ||
| Q1 25 | $1.4B | $810.8M | ||
| Q4 24 | $1.4B | $840.9M | ||
| Q3 24 | $1.3B | $667.7M | ||
| Q2 24 | $1.3B | $704.2M | ||
| Q1 24 | $1.2B | $762.2M |
总资产DCOMZLAB
| Q4 25 | $15.3B | $1.2B | ||
| Q3 25 | $14.5B | $1.2B | ||
| Q2 25 | $14.2B | $1.2B | ||
| Q1 25 | $14.1B | $1.2B | ||
| Q4 24 | $14.4B | $1.2B | ||
| Q3 24 | $13.7B | $985.3M | ||
| Q2 24 | $13.5B | $987.4M | ||
| Q1 24 | $13.5B | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $186.6M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.7M |
| 自由现金流率自由现金流/营收 | — | -21.0% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流DCOMZLAB
| Q4 25 | $186.6M | $-26.0M | ||
| Q3 25 | $52.1M | $-32.0M | ||
| Q2 25 | $23.1M | $-31.0M | ||
| Q1 25 | $65.4M | $-61.7M | ||
| Q4 24 | $99.1M | $-55.8M | ||
| Q3 24 | $-33.3M | $-26.8M | ||
| Q2 24 | $12.6M | $-42.2M | ||
| Q1 24 | $30.7M | $-90.1M |
自由现金流DCOMZLAB
| Q4 25 | — | $-26.7M | ||
| Q3 25 | $51.2M | $-35.0M | ||
| Q2 25 | $20.4M | $-33.9M | ||
| Q1 25 | — | $-63.2M | ||
| Q4 24 | — | $-58.4M | ||
| Q3 24 | $-34.1M | $-28.2M | ||
| Q2 24 | $9.2M | $-42.9M | ||
| Q1 24 | — | $-91.1M |
自由现金流率DCOMZLAB
| Q4 25 | — | -21.0% | ||
| Q3 25 | 44.3% | -30.4% | ||
| Q2 25 | 18.6% | -31.1% | ||
| Q1 25 | — | -59.9% | ||
| Q4 24 | — | -53.8% | ||
| Q3 24 | -38.9% | -27.7% | ||
| Q2 24 | 10.5% | -42.9% | ||
| Q1 24 | — | -104.5% |
资本支出强度DCOMZLAB
| Q4 25 | — | 0.5% | ||
| Q3 25 | 0.7% | 2.6% | ||
| Q2 25 | 2.4% | 2.6% | ||
| Q1 25 | — | 1.5% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | 0.9% | 1.3% | ||
| Q2 24 | 3.9% | 0.7% | ||
| Q1 24 | — | 1.1% |
现金转化率DCOMZLAB
| Q4 25 | — | — | ||
| Q3 25 | 1.88× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 3.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -2.50× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 1.74× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCOM
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
